
    
      A randomized, double-blind, parallel group, multicentre phase IIIb study to compare
      ticagrelor with clopidogrel treatment on the risk of cardiovascular death, myocardial
      infarction and ischemic stroke in patients with established Peripheral Artery Disease (EUCLID
      Examining Use of tiCagreLor In paD)
    
  